Neocleus vs XenSource
Neocleus vs XenSource, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Neocleus is on 39/100 and XenSource on 34/100.
Where each one leads
Neocleus
- our overall score: 39/100 against 34/100
XenSource
- funding raised: $50.0M against $17.1M
At a glance
| Measure | Neocleus | XenSource |
|---|---|---|
| What it is | Neocleus was a software company that developed virtualization and cloud management solutions for enterprises. | XenSource was a virtualization software company that developed and commercialized the open-source Xen hypervisor. |
| Category | Virtualization, Cloud Management, Enterprise Software, Data Center Management | Virtualization, Server Virtualization, Cloud Infrastructure, Data Center Infrastructure |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2006 | 2004 |
| Headquarters | Herzliya, Israel | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Neocleus | XenSource |
|---|---|---|
| Total funding | $17.1M | $50.0M |
| Latest round | Series B | Series C |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Neocleus | XenSource |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 34/100 |
| Traction | 36/100 | 38/100 |
| Team | 60/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 2/100 | 3/100 |
| Quality | 45/100 | 30/100 |
Neocleus vs XenSource: common questions
Which is better, Neocleus or XenSource?
On our 0-100 score Neocleus rates higher (39/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Neocleus and XenSource compare on the numbers?
Neocleus leads on our overall score (39/100 against 34/100). XenSource leads on funding raised ($50.0M against $17.1M).
Read the full Neocleus review and pricing or the XenSource review and pricing. You can also browse other Neocleus alternatives we track.